Oregon has passed Measure 109 which has created a 2 year development period for the generation of Psilocybin Service Centers in all agreeing Oregon counties/municipalities. This period ends in January 2023, at which time service centers may obtain a license from the Oregon Health Authority, hire service facilitators who meet the criteria for providing facilitation, and administer fungal-product to clients on service center grounds.
Strategizing how to provide equitable services
Education regarding helpful on-hand medical supplies
Recommendations on screening clients for candidacy for services
Consultation on moderate or high complexity clients seeking services
Many providers, both in the medical paradigm and in other healing paradigms, can benefit from case consultation with an expert psychiatrist. Penumbra provides this service on a sliding-scale depending on the paradigm in which consultation is requested.
The following is a copy of the informed consent document (OAR 333-333-5040) provided to anyone about to receive psilocybin at a service center in Oregon. This document demonstrates a number of the safeguards as well as some of the pitfalls of services in Oregon. I’ve put in bold the highlights. In the State of Oregon, […]
What is the Oregon Psilocybin Services Act? What is Being Consumed? Who Can Consume? Who Cannot Consume? Who Are The Facilitators & What Are Their Duties? What Do Psilocybin Services Look Like? Other Pertinent Details
As it turns out, moose, caribou, and, yes, reindeer will occasion upon Amanita muscaria mushrooms. Also known as Fly Agaric, this mushroom is easily identifiable by its bright red appearance and white spots (we’ve all played Super Mario right?), not all too dissimilar to the appearance of Santa Claus… Could there be some relationship between […]
For those who are seeking to participate in a clinical trial involving psilocybin, I will be outlining below how to easily identify and reach out to potential clinical trials. This article should prove useful to patients and professionals who are looking to refer their patients to an appropriate study. STEP 1: Get to ClinicalTrials.gov This […]